HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ZSTK474

phosphatidylinositol 3-kinase inhibitor; structure in first source
Also Known As:
2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine
Networked: 19 relevant articles (0 outcomes, 1 trials/studies) for this Bio-Agent, Comments

Bio-Agent Context: Research Results

Experts

1. Yamori, Takao: 9 articles (11/2012 - 04/2006)
2. Yoshimi, Hisashi: 5 articles (04/2012 - 04/2006)
3. Dan, Shingo: 4 articles (11/2012 - 01/2009)
4. Okamura, Mutsumi: 4 articles (04/2012 - 01/2009)
5. Kong, Dexin: 3 articles (01/2013 - 10/2007)
6. Tamura, Naoto: 3 articles (06/2012 - 01/2010)
7. Yancey, Dana: 2 articles (10/2013 - 01/2013)
8. Sui, Guangchao: 2 articles (10/2013 - 01/2013)
9. Pullikuth, Ashok: 2 articles (10/2013 - 01/2013)
10. Kulik, George: 2 articles (10/2013 - 01/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Pancreatic Neoplasms (Pancreatic Cancer)
3. Prostatic Neoplasms (Prostate Cancer)
4. Arthritis (Polyarthritis)
5. Experimental Arthritis

Related Drugs and Biologics

1. Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
2. Sirolimus (Rapamycin)
3. Single-Chain Antibodies
4. Proteasome Endopeptidase Complex (Proteasome)
5. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
6. Serum-Free Culture Media
7. Staphylococcal Protein A (A, Protein)
8. Immunotoxins (Immunotoxin)
9. KP372-1
10. monoclonal antibody J591

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Oral Administration

blog comments powered by Disqus
TREATMENT OPTIONS
for Neoplasms,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 27977 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>